PT651654E - Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa - Google Patents

Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa

Info

Publication number: PT651654E
Authority: PT; Portugal
Prior art keywords: lisozimase; dental; preparation; medicinal product; defense mechanisms
Prior art date: 1992-07-13

Application number

PT93915903T

Other languages

English (en)

Inventor

Witold Kiczka

Original Assignee

Nika Health Products Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-13

Filing date

1993-07-13

Publication date

2004-03-31

1993-07-13 Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd

2004-03-31 Publication of PT651654E publication Critical patent/PT651654E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Microbiology (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Heart & Thoracic Surgery (AREA)
General Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT93915903T 1992-07-13 1993-07-13 Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa PT651654E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL92295273A PL173978B1 (pl)	1992-07-13	1992-07-13	Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej

Publications (1)

Publication Number	Publication Date
PT651654E true PT651654E (pt)	2004-03-31

Family

ID=20058087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT93915903T PT651654E (pt)	1992-07-13	1993-07-13	Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa

Country Status (31)

Country	Link
US (1)	US6132715A (pt)
EP (1)	EP0651654B1 (pt)
JP (1)	JPH07508744A (pt)
KR (1)	KR100289841B1 (pt)
CN (1)	CN1057937C (pt)
AT (1)	ATE252392T1 (pt)
AU (1)	AU677786B2 (pt)
BG (1)	BG63331B1 (pt)
BR (1)	BR9306722A (pt)
CA (1)	CA2140140A1 (pt)
CZ (1)	CZ286725B6 (pt)
DE (2)	DE651654T1 (pt)
DK (1)	DK0651654T3 (pt)
ES (1)	ES2074037T3 (pt)
FI (1)	FI950144A0 (pt)
GE (1)	GEP20012466B (pt)
GR (1)	GR950300039T1 (pt)
HU (1)	HU218151B (pt)
MX (1)	MX9304197A (pt)
NZ (2)	NZ254135A (pt)
OA (1)	OA10125A (pt)
PL (1)	PL173978B1 (pt)
PT (1)	PT651654E (pt)
RO (1)	RO112580B1 (pt)
RU (1)	RU2145875C1 (pt)
SG (1)	SG52727A1 (pt)
SK (1)	SK282377B6 (pt)
TW (1)	TW259710B (pt)
UA (1)	UA49789C2 (pt)
WO (1)	WO1994001127A1 (pt)
ZA (1)	ZA935046B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6183742B1 (en)	1992-07-13	2001-02-06	Nika Health Products, Limited	Applications of lysozyme dimer
DZ1964A1 (fr) *	1995-01-13	2002-10-15	Nika Health Products Ltd	Nouvelle applications d'un dimère de lysozyme.
EP0793472A4 (en) *	1995-05-30	2000-12-27	Lectin Biopharma Inc	METHOD FOR USING LECTINES FOR AGGLUTINATION AND FOR COLLECTING MENSTRUATION FLUIDS
US6123937A (en) *	1997-03-14	2000-09-26	Nika Health Products, Limited	Applications of lysozyme dimer
ITMI981148A1 (it)	1998-05-22	1999-11-22	Therapicon Srl	Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
EP1174147A1 (en) *	2000-06-27	2002-01-23	Nika Health Products Limited	Reversal of antibiotic resistance with lysozyme dimer
US20050244402A1 (en) *	2004-04-30	2005-11-03	Villanueva Julie M	Absorption of pain-causing agents
RU2472467C2 (ru) *	2011-04-13	2013-01-20	Государственное научное учреждение Краснодарский научно-исследовательский ветеринарный институт (ГНУ КНИВИ)	Способ профилактики и лечения гастроэнтеритов, обусловленных бактериозами, у телят
RU2546911C2 (ru) *	2013-04-11	2015-04-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Донской государственный аграрный университет"	Способ хранения свинины в охлажденном состоянии
CN105106626A (zh) *	2015-09-30	2015-12-02	成都倍加特生物科技有限公司	一种治疗月经期感染的汤剂药物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR4020M (pt) *	1965-01-29	1966-03-21
FR2215201A1 (en) *	1973-01-24	1974-08-23	Theranol Lab	Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent
JPS5533408A (en) *	1978-08-30	1980-03-08	Eisai Co Ltd	Immunity-increasing agent
JPS5533409A (en) *	1978-08-30	1980-03-08	Eisai Co Ltd	Carcinostatic agent
JPS5543040A (en) *	1978-09-25	1980-03-26	Eisai Co Ltd	Immunity raising agent
US4221794A (en) *	1979-06-21	1980-09-09	Newport Pharmaceuticals International, Inc.	Method of imparting immunomodulating and antiviral activity
US4457919A (en) *	1980-03-14	1984-07-03	Newport Pharmaceutical International, Inc.	Method of imparting immunomodulating, antiviral or antitumor activity
US4510144A (en) *	1981-08-26	1985-04-09	Newport Pharmaceuticals International	Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4739046A (en) *	1985-08-19	1988-04-19	Luzio Nicholas R Di	Soluble phosphorylated glucan
US4744984A (en) *	1985-10-08	1988-05-17	Vetrepharm Research, Inc.	Antiviral immunotherapeutic agent and preparation thereof
DE3782958D1 (de) *	1986-02-19	1993-01-21	Imreg Inc	Verfahren und mittel zum pruefen eines immunsystems.
US5200182A (en) *	1988-05-26	1993-04-06	Nika Health Products, Ltd.	Antiviral or antibacterial composition and method of use
DE3817955A1 (de) *	1988-05-27	1989-11-30	Hoechst Ag	Tnf-inhibitor enthaltendes arzneimittel
JP2568447B2 (ja) *	1988-05-31	1997-01-08	ナップ・システムズ・（ユーエスエイ）・インコーポレーテッド	印刷原板を処理するための装置及び方法
WO1991000092A1 (en) *	1989-06-13	1991-01-10	Smithkline Beecham Corporation	Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
SG49871A1 (en) *	1990-01-08	1998-06-15	Nika Health Products Ltd	Method of preparing lysozyme dimers
US5314816A (en) *	1990-01-08	1994-05-24	Nika Health Products Ltd.	Method of preparing lysozyme dimers
CA2088352A1 (en) *	1990-08-03	1992-02-04	Klaus M. Esser	Tnf inhibitors

1992
- 1992-07-13 PL PL92295273A patent/PL173978B1/pl not_active IP Right Cessation
1993
- 1993-07-13 BR BR9306722A patent/BR9306722A/pt not_active Application Discontinuation
- 1993-07-13 SK SK40-95A patent/SK282377B6/sk not_active IP Right Cessation
- 1993-07-13 CN CN93116771A patent/CN1057937C/zh not_active Expired - Fee Related
- 1993-07-13 AT AT93915903T patent/ATE252392T1/de not_active IP Right Cessation
- 1993-07-13 WO PCT/EP1993/001841 patent/WO1994001127A1/en active IP Right Grant
- 1993-07-13 DK DK93915903T patent/DK0651654T3/da active
- 1993-07-13 ES ES93915903T patent/ES2074037T3/es not_active Expired - Lifetime
- 1993-07-13 EP EP93915903A patent/EP0651654B1/en not_active Expired - Lifetime
- 1993-07-13 UA UA95018021A patent/UA49789C2/uk unknown
- 1993-07-13 DE DE0651654T patent/DE651654T1/de active Pending
- 1993-07-13 CZ CZ199585A patent/CZ286725B6/cs not_active IP Right Cessation
- 1993-07-13 AU AU45686/93A patent/AU677786B2/en not_active Ceased
- 1993-07-13 HU HU9500098A patent/HU218151B/hu not_active IP Right Cessation
- 1993-07-13 GE GEAP19932466A patent/GEP20012466B/en unknown
- 1993-07-13 JP JP6502985A patent/JPH07508744A/ja active Pending
- 1993-07-13 NZ NZ254135A patent/NZ254135A/en not_active IP Right Cessation
- 1993-07-13 PT PT93915903T patent/PT651654E/pt unknown
- 1993-07-13 ZA ZA935046A patent/ZA935046B/xx unknown
- 1993-07-13 RU RU95105517A patent/RU2145875C1/ru not_active IP Right Cessation
- 1993-07-13 RO RO95-00041A patent/RO112580B1/ro unknown
- 1993-07-13 SG SG1996008336A patent/SG52727A1/en unknown
- 1993-07-13 DE DE69333258T patent/DE69333258T2/de not_active Expired - Lifetime
- 1993-07-13 MX MX9304197A patent/MX9304197A/es not_active IP Right Cessation
- 1993-07-13 KR KR1019940704649A patent/KR100289841B1/ko not_active IP Right Cessation
- 1993-07-13 CA CA002140140A patent/CA2140140A1/en not_active Abandoned
- 1993-08-03 TW TW082106180A patent/TW259710B/zh active
1994
- 1994-12-22 BG BG99287A patent/BG63331B1/bg unknown
1995
- 1995-01-12 FI FI950144A patent/FI950144A0/fi unknown
- 1995-01-13 OA OA60604A patent/OA10125A/en unknown
- 1995-06-07 US US08/476,561 patent/US6132715A/en not_active Expired - Fee Related
- 1995-07-31 GR GR950300039T patent/GR950300039T1/el unknown
1996
- 1996-09-13 NZ NZ299377A patent/NZ299377A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9500098D0 (en)	1995-03-28
WO1994001127A1 (en)	1994-01-20
BR9306722A (pt)	1998-12-08
OA10125A (en)	1996-12-18
ES2074037T1 (es)	1995-09-01
HU218151B (hu)	2000-06-28
KR100289841B1 (ko)	2001-05-15
CN1057937C (zh)	2000-11-01
BG63331B1 (bg)	2001-10-31
RU2145875C1 (ru)	2000-02-27
PL173978B1 (pl)	1998-05-29
KR950702432A (ko)	1995-07-29
US6132715A (en)	2000-10-17
GEP20012466B (en)	2001-06-25
NZ254135A (en)	1996-11-26
ATE252392T1 (de)	2003-11-15
NZ299377A (en)	2001-02-23
FI950144L (fi)	1995-01-12
CZ8595A3 (en)	1995-09-13
TW259710B (pt)	1995-10-11
SK4095A3 (en)	1995-09-13
RO112580B1 (ro)	1997-11-28
CA2140140A1 (en)	1994-01-20
DE69333258T2 (de)	2004-08-26
PL295273A1 (en)	1994-01-24
FI950144A0 (fi)	1995-01-12
DE651654T1 (de)	1996-01-04
EP0651654B1 (en)	2003-10-22
BG99287A (bg)	1995-08-28
DK0651654T3 (da)	2004-02-23
AU677786B2 (en)	1997-05-08
DE69333258D1 (de)	2003-11-27
JPH07508744A (ja)	1995-09-28
ES2074037T3 (es)	2004-07-01
CN1087278A (zh)	1994-06-01
MX9304197A (es)	1994-02-28
CZ286725B6 (en)	2000-06-14
AU4568693A (en)	1994-01-31
HUT70973A (en)	1995-11-28
ZA935046B (en)	1994-02-07
EP0651654A1 (en)	1995-05-10
SG52727A1 (en)	1998-09-28
GR950300039T1 (en)	1995-07-31
UA49789C2 (uk)	2002-10-15
SK282377B6 (sk)	2002-01-07

Publication	Publication Date	Title
BR9815439A (pt)	2001-10-16	Analgesia contìnua obtida com buprenorphine
FI103180B1 (fi)	1999-05-14	Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehdusten torjumiseksi eläimissä ja ihmisissä
MX171191B (es)	1993-10-06	Composiciones farmaceuticas de glipizida
DE68910159D1 (de)	1993-12-02	Dosierform für Verabreichung in der Humanmedizin.
PT671910E (pt)	2004-12-31	Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
IT1261849B (it)	1996-06-03	Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
FI875533L (fi)	1987-12-16	Insulinpreparat foer non-parenteral dosering.
DE69330032D1 (de)	2001-04-19	Therapeutisches kombinationspräparat enthaltend interferon
NO306377B1 (no)	1999-11-01	Doseform for avgivelse av et medikament
SE9301290D0 (sv)	1993-04-20	Anvaendning av en somatostatinanalog
IT1170214B (it)	1987-06-03	Composizione farmaceutica per la cura delle arteriopatie periferiche
DE58901002D1 (de)	1992-04-30	Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
PT651654E (pt)	2004-03-31	Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
RU95101385A (ru)	1996-12-27	Продукты, содержащие g-csf и tnf связующие протеина
KR910005858A (ko)	1991-04-27	지방산 요법
SE9200199D0 (sv)	1992-01-24	Farmaceutisk komposition och dess anvaendning
DE3585835D1 (de)	1992-05-14	Praeparat zur intramuskulaeren injektion von medikamenten, vitaminen oder impfstoffen.
EA199800770A1 (ru)	1999-02-25	Лекарственный препарат для терапевтического лечения вирусного гепатита
KR900701311A (ko)	1990-12-01	재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
RU94000695A (ru)	1996-11-20	Средство с противоаллергическим действием
ITPD920102A1 (it)	1993-12-05	Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico
RO81269B1 (ro)	1983-02-28	MEDICAMENT ACTIV îN TRATAMENTUL ARSURILOR SI PLAGILOR
JPS6333336A (ja)	1988-02-13	有十
RU93016030A (ru)	1996-11-10	Лекарственное средство, стимулирующее гранулоцитарный росток кроветворения при цитостатических миелодепрессиях
RU94002713A (ru)	1996-06-10	Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)